A Search Service for Abbreviation / Long Form

■ Abbreviation / Long Form : PCR / pentostatin, cyclophosphamide, and rituximab

[Related PubMed/MEDLINE] Total Number of Papers: 6 [Entries Per Page] 5 10 20 50 100  per page Page Control Page: of			Abbreviation:   PCR  (>> Co-occurring Abbreviation) Long Form:   pentostatin, cyclophosphamide, and rituximab  Abbreviation Variation      PCR (6 times)  Long Form Variation      pentostatin, cyclophosphamide, and rituximab (3 times)      Pentostatin, cyclophosphamide, and rituximab (1 time)      pentostatin, cyclophosphamide and rituximab (1 time)      Pentostatin, Cyclophosphamide and Rituximab (1 time)  Pair(Abbreviation/Long Form) Variation      PCR / pentostatin, cyclophosphamide, and rituximab (3 times)      PCR / Pentostatin, cyclophosphamide, and rituximab (1 time)      PCR / pentostatin, cyclophosphamide and rituximab (1 time)      PCR / Pentostatin, Cyclophosphamide and Rituximab (1 time) No. Year Title Co-occurring Abbreviation 1  2019 Pentostatin, Cyclophosphamide, and Rituximab Followed by Alemtuzumab for Relapsed or Refractory Chronic Lymphocytic Leukemia: A Phase 2 Trial of the ECOG-Acrin Cancer Research Group (E2903). CIT, CLL, OS, PR, R/R 2  2016 A randomized phase II trial comparing chemoimmunotherapy with or without bevacizumab in previously untreated patients with chronic lymphocytic leukemia. CLL, CR, PFS, TFS, VEGF 3  2016 Pentostatin, Cyclophosphamide and Rituximab (PCR) Regimen. --- 4  2013 Long-term repair of T-cell synapse activity in a phase II trial of chemoimmunotherapy followed by lenalidomide consolidation in previously untreated chronic lymphocytic leukemia (CLL). CIT, CLL 5  2007 Community-based phase II trial of pentostatin, cyclophosphamide, and rituximab (PCR) biochemotherapy in chronic lymphocytic leukemia and small lymphocytic lymphoma. CLL, SLL 6  2003 Pentostatin and cyclophosphamide: an effective new regimen in previously treated patients with chronic lymphocytic leukemia. CLL